Loewenstein, Anat
Trivizki, Omer http://orcid.org/0000-0003-3887-6238
Funding for this research was provided by:
Iveric Bio Inc
Article History
Received: 14 July 2022
Revised: 7 November 2022
Accepted: 28 November 2022
First Online: 15 December 2022
Declarations
:
: This review article does not contain any studies with human participants or animals performed by any of the others.
: Anat Loewenstein is a consultant to Iveric Bio, Beyeonics, Bayer, WebMD, Allergan, Roche, Novartis, Notal Vision. Omer Trivizki declares no conflicts of interest.